Tag results:

Industry & Policy News

SparX Biopharmaceutical Announces FDA Greenlight for IND Application of SPX-303, A First-In-Human anti-LILRB2/PD-L1 Antibody Drug

[SparX Biopharmaceutical Corp. (Cision Newswire)] The company is primed to launch a Phase I clinical study, aiming to assess the safety, tolerability, and preliminary efficacy of SPX-303 in patients beleaguered by advanced or refractory solid tumors.

Dengue Rates Drop After Release of Modified Mosquitoes in Colombia

[Nature] Three cities in Colombia saw a dramatic fall in the incidence of dengue in the years following the introduction of mosquitoes carrying Wolbachia, a bacterium that prevents the insect from transmitting viruses. In neighbourhoods where the Wolbachia mosquitoes were well established, dengue incidence dropped by 94–97%.

The Prostate Cancer Foundation Announces The 2023 Young Investigator Awards Totaling More Than $6 Million for Prostate Cancer Research

[Prostate Cancer Foundation] The Prostate Cancer Foundation announced the Class of 2023 Young Investigator Award recipients totaling $6.1 million in funding for innovative prostate cancer research.

Oncternal Therapeutics Announces FDA Granted Fast Track Designation for ONCT-534 for the Treatment of Metastatic Castration-Resistant Prostate Cancer

[Oncternal Therapeutics, Inc.] ONCT-534 interacts with both the N-terminal domain and the ligand-binding domain of the androgen receptor, inhibiting cell growth and inducing androgen receptor degradation.

Velico Medical launches Blood Center Education Program with South Texas Blood & Tissue

[Velico (PR Newswire)] Velico Medical announced the launch of its Blood Center Education Program (BCEP) at South Texas Blood & Tissue. Velico's BCEP is designed to generate deep customer feedback on the commissioning and operational aspects of the FrontlineODP™ system for spray drying plasma.

First Detailed US Scientific Integrity Draft Policies Get Mixed Responses

[ScienceInsider] Keep working on it. That’s the reaction of US science watchdog groups to the first attempts by federal health agencies to flesh out a promise by President Joe Biden to restore trust in government by ensuring that government scientists are free to do their jobs without political meddling.

Popular